Left atrial appendage occlusion: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Heart_left_atrial_appendage_tee_view.jpg|Heart left atrial appendage TEE view | |||
File:Herzohrclip_-_Roe_pa_und_seitlich_-_Auschnitt_-_001.jpg|Herzohrclip - Roe pa und seitlich - Auschnitt | |||
</gallery> | |||
Latest revision as of 01:33, 18 February 2025
Left atrial appendage occlusion (LAAO) is a medical procedure used to reduce the risk of stroke in patients with atrial fibrillation. The procedure involves the closure or occlusion of the left atrial appendage (LAA), a small, ear-shaped sac in the muscle wall of the top left chamber of the heart that is believed to be the source of a large majority of blood clots in patients with atrial fibrillation.
Procedure[edit]
The LAAO procedure is performed by a cardiologist who specializes in the treatment of heart rhythm disorders (electrophysiologist). The procedure is typically performed under general anesthesia. The cardiologist uses imaging techniques such as transesophageal echocardiography (TEE) and fluoroscopy to guide the placement of the occlusion device.
The device is inserted through a small incision in the groin and guided through the vascular system to the heart. Once in place, the device is used to seal off the LAA, preventing blood clots from escaping.
Risks and Complications[edit]
Like all medical procedures, LAAO carries some risks. These may include bleeding, infection, damage to the heart or blood vessels, stroke, or death. However, the risk of these complications is generally low.
Effectiveness[edit]
Studies have shown that LAAO is an effective treatment for reducing the risk of stroke in patients with atrial fibrillation. It is particularly beneficial for patients who are at high risk for stroke and who are not suitable candidates for long-term anticoagulation therapy.


